首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Reviews in cardiovascular medicine

缩写:REV CARDIOVASC MED

ISSN:1530-6550

e-ISSN:2153-8174

IF/分区:1.3/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1878
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xiaohe Wang,Liwei Fan,Qiang Yuan et al. Xiaohe Wang et al.
Myocardial fibrosis represents the initial stage of cardiac failure and is characterized by the accumulation of extracellular matrix proteins. The fibrogenic niche provides a unique microenvironment for myocardial fibrosis and consists prim...
Jose Arriola-Montenegro,Andres Chaponan-Lavalle,Natalia Nombera-Aznaran et al. Jose Arriola-Montenegro et al.
Resistant hypertension (RH) is a high-risk phenotype characterized by blood pressure readings ≥130/80 mmHg despite maximally tolerated therapy with three antihypertensive agents, including a diuretic, or controlled blood pressure requiring...
Javier Urmeneta Ulloa,Vicente Martínez de Vega,Isabel Molina Borao et al. Javier Urmeneta Ulloa et al.
Four-dimensional (4D) flow cardiac magnetic resonance (CMR) is an advanced imaging modality that enables comprehensive qualitative and quantitative assessment of blood flow in the three spatial dimensions plus time. This technique is more a...
Lijia Xu,Haojie Yang,Chaojie He et al. Lijia Xu et al.
Emerging evidence has implicated the gut microbiota in the pathogenesis and progression of numerous cardiovascular diseases. Atherosclerosis is a major pathological process that leads to many severe cardiovascular complications. Meanwhile, ...
Xiaozheng Zhou,Yilin Pan,Kun Hua et al. Xiaozheng Zhou et al.
Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors, a novel class of oral antihyperglycemic medications prescribed for type 2 diabetes mellitus, play a beneficial role in slowing the progression of heart failur...
Karl Jakob Weiss,Shing Ching,Patrick Doeblin et al. Karl Jakob Weiss et al.
Background: Magnetic resonance imaging (MRI) allows for the assessment of myocardial strain and identification of heart failure (HF) patients with reduced (HFrEF), mildly reduced (HFmrEF), or preserved (HFpEF) left ventri...
Vikash Jaiswal,Yusra Mashkoor,Vamsikalyan Borra et al. Vikash Jaiswal et al.
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been shown to reduce major adverse cardiovascular events (MACEs) in patients with type 2 diabetes mellitus (T2DM) and high cardiovascular risk. Howeve...
Lucianne West,Harsh Patolia,Brittany Chapman et al. Lucianne West et al.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed for glycemic control in type 2 diabetes, have emerged as transformative agents with broad therapeutic applications across multiple organ systems. This review explor...
Farbod Sedaghat-Hamedani,Elham Kayvanpour,Benjamin Meder Farbod Sedaghat-Hamedani
Hypertrophic cardiomyopathy (HCM) represents the most common inherited cardiac disease and a leading cause of heart failure, arrhythmias, and sudden cardiac death in young individuals. For decades, management of HCM has relied on symptom co...
Zhenzhen Li,Dawei Lin,Jianing Fan et al. Zhenzhen Li et al.
With ongoing technological advancements and device innovations, transcatheter aortic valve replacement (TAVR) has become a well-established therapeutic approach for managing aortic stenosis and regurgitation. As indications for TAVR expand,...